Scar management: prevention and treatment strategies. [2005.08]
Pitfalls of midface surgery. [2005.08]
Niacinamide-containing facial moisturizer improves skin barrier and benefits subjects with rosacea. [2005.08]
Multipass vector (mpave) technique with nonablative radiofrequency to treat facial and neck laxity. [2005.08]
DeoxyArbutin: a novel reversible tyrosinase inhibitor with effective in vivo skin lightening potency. [2005.08]
Creatine supplementation normalizes mutagenesis of mitochondrial DNA as well as functional consequences. [2005.08]
Complications of rhytidectomy. [2005.08]
Comparison of a 1,064 nm laser and a 1,320 nm laser for the nonablative treatment of acne scars. [2005.08]
Interventions for rosacea. [2005.07.20]
Topical vitamin C: a useful agent for treating photoaging and other dermatologic conditions. [2005.07]
Results of a randomised, multicentre study comparing a new water-based gel of clindamycin 1% versus clindamycin 1% topical solution in the treatment of acne vulgaris. [2005.07]
Novel approach to the treatment of hyperpigmented photodamaged skin: 4% hydroquinone/0.3% retinol versus tretinoin 0.05% emollient cream. [2005.07]
Niacinamide: A B vitamin that improves aging facial skin appearance. [2005.07]
Injected hyaluronidase reduces restylane-mediated cutaneous augmentation. [2005.07]
Effects of endoscopic forehead/midface-lift on lower eyelid tension. [2005.07]
Double-blinded, placebo-controlled trial of green tea extracts in the clinical and histologic appearance of photoaging skin. [2005.07]
Comparison of intense pulsed light to 595-nm long-pulsed pulsed dye laser for treatment of hypertrophic surgical scars: a pilot study. [2005.07]
Topical application of 17beta-estradiol increases extracellular matrix protein synthesis by stimulating tgf-Beta signaling in aged human skin in vivo. [2005.06]
Increased expression of 14-3-3varepsilon protein in intrinsically aged and photoaged human skin in vivo. [2005.06]
Filling agents. [2005.06]
Combination sodium sulfacetamide 10% and sulfur 5% cream with sunscreens versus metronidazole 0.75% cream for rosacea. [2005.06]
Treatment of periorbital rhytids with botulinum toxin type A: maximizing safety and results. [2005.05]
Topography and anisotropy of the skin surface with ageing. [2005.05]
Scar sarcoidosis after hyaluronic acid injection. [2005.05]
Rosacea, light, and phototherapy. [2005.05]
Pimecrolimus for treatment of acne rosacea. [2005.05]
Is topical anesthesia useful in noninvasive skin tightening using radiofrequency? [2005.05]
Comparison of efficacy of azithromycin vs. doxycycline in the treatment of acne vulgaris. [2005.05]
Combination therapy with adapalene gel 0.1% and doxycycline for severe acne vulgaris: a multicenter, investigator-blind, randomized, controlled study. [2005.05]
A randomized, double-blind, placebo-controlled study on the clinical efficacy of oral treatment with DermaVite on ageing symptoms of the skin. [2005.05]
A randomized controlled trial of laser treatment among hirsute women with polycystic ovary syndrome. [2005.05]
Treatment of photoaged skin with a cream containing 0.05% isotretinoin and sunscreens. [2005.04]
The evolution of soft tissue fillers in clinical practice. [2005.04]
Soft tissue implants and fillers. [2005.04]
Injectable skin fillers. [2005.04]
Dose-ranging study of botulinum toxin type A in the treatment of glabellar rhytids in females. [2005.04]
[Perolen cream for therapy of rosacea.] [2005.03]
Vitamin E does not reduce the side-effects of isotretinoin in the treatment of acne vulgaris. [2005.03]
Utilizing fractional resurfacing in the treatment of therapy-resistant melasma. [2005.03]
Ultrastructural changes seen after ALA-IPL photorejuvenation: a pilot study. [2005.03]
Treatment of nasal wrinkles with botulinum toxin. [2005.03]
The rigor of trials evaluating Rosacea treatments. [2005.03]
Tazarotene cream versus adapalene cream in the treatment of facial acne vulgaris: a multicenter, double-blind, randomized, parallel-group study. [2005.03]
Safety and efficacy of nonanimal stabilized hyaluronic acid for improvement of mouth corners. [2005.03]
Present and future rosacea therapy. [2005.03]
Managing inflammatory reaction to restylane. [2005.03]
Lasers and light sources for rosacea. [2005.03]
Enhanced full-face skin rejuvenation using synchronous intense pulsed optical and conducted bipolar radiofrequency energy (ELOS): introducing selective radiophotothermolysis. [2005.03]
Double-blind, randomized, placebo-controlled, dose-response study of the safety and efficacy of botulinum toxin type A in subjects with crow's feet. [2005.03]
Corrective cosmetics are effective for women with facial pigmentary disorders. [2005.03]
<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Next >>
